Open-label, randomised, clinical trial to evaluate the immunogenicity and safety of a prophylactic vaccination of healthcare providers by administration of a heterologous vaccine regimen against Ebola in the Democratic Republic of the Congo: the study protocol

• Jean-Pierre Van Geertruyden,
• Pierre Van Damme,
• Ynke Larivière,
• Vivi Maketa,
• Junior Matangila,
• Patrick Mitashi,
• Jessie De Bie,
• Trésor Zola,
• Elke Stoppie,
• Hypolite Muhindo-Mavoko

Affiliations

Jean-Pierre Van Geertruyden

Global Health Institute, University of Antwerp, Wilrijk, Belgium

Pierre Van Damme

Centre for Evaluation of Vaccination, University of Antwerp, Wilrijk, Belgium

Ynke Larivière

Centre for Evaluation of Vaccination, University of Antwerp, Wilrijk, Belgium

Vivi Maketa

Tropical Medicine Department, University of Kinshasa, Kinshasa, Congo (the Democratic Republic of the)

Junior Matangila

Tropical Medicine Department, University of Kinshasa, Kinshasa, Congo (the Democratic Republic of the)

Patrick Mitashi

Tropical Medicine Department, University of Kinshasa, Kinshasa, Congo (the Democratic Republic of the)

Jessie De Bie

Centre for Evaluation of Vaccination, University of Antwerp, Wilrijk, Belgium

Trésor Zola

Tropical Medicine Department, University of Kinshasa, Kinshasa, Congo (the Democratic Republic of the)

Elke Stoppie

Centre for Evaluation of Vaccination, University of Antwerp, Wilrijk, Belgium

Hypolite Muhindo-Mavoko

Tropical Medicine Department, University of Kinshasa, Kinshasa, Congo (the Democratic Republic of the)